Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Press/Media

Period2 Oct 2018

Media coverage

1

Media coverage

  • TitleInduction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
    Media name/outletClinical Trials.gov
    Country/TerritoryUnited States
    Date2/10/18
    PersonsJerry Liu
View all 1
View less